Member Info for countingcards

Hi Jace hope you are well mate. Yes slowly getting to the point of no return lower. You almost feel like you dont want it to go yet until you have added more. Each time you promise, "that's it no more!" but even Martin Lang has seen the light.

Dawn Coverley has gone from 13359042 to 17,048,137 which is a rise of 3,689,096.

Allan Miller has gone from 2025511 to 14,858,844 a rise of 12,833,333

Finally no trace of Martin Lang previously so that a new holding of 26,109,570. No record of them holding any before this announcement.

If my calculations are correct they have sold down 17,722,276 shares, and now hold 33,280,000 or 9.84%.

Excellent posts from m007j and also DaveTK. TP selling has given many the opportunity to add buckets at these low prices and depressed times by selling.

November 1st 2022
J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies
https://am.jpmorgan.com/us/en/asset-management/adv/about-us/media/press-releases/jp-morgan-launches-new-life-sciences-private-capital-team-targeting-investments-in-innovative-healthcare-companies/

(courtesy of the above link) "Laurie H. Glimcher, M.D. was named President and CEO of the Dana-Farber Cancer Institute in 2016. She is also Director of the Dana-Farber/Harvard Cancer Center and the Richard and Susan Smith Professor of Medicine at Harvard Medical School. Previously, she was the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. Dr. Glimcher is a distinguished immunologist, widely renowned for her work in one of the most promising areas of cancer research. "

https://www.dana-farber.org/about-us/leadership/laurie-glimcher/
(courtesy of the above link) "A trailblazer in cancer research, Dr. Glimcher's research identified key transcriptional regulators of protective immunity and the origin of pathophysiologic immune responses underlying autoimmune, infectious, and malignant diseases. Dr. Glimcher speaks nationally and internationally on cancer, immunology, skeletal biology, and translational medicine, and has contributed more than 350 scholarly articles and papers to the medical literature."

My own target for the end of Dec 23 is 4.65p based only on my own current holding and what I would want projection wise. Anything above that would be a bonus. Anything below that and if funds were available (which they will be) would be a further buying opportunity. Again this would be based on current business continuing its projected growth.

No idea if anyone is selling/buying and not really concerned if they are, and 359 days from now is a different scenario to 5 minutes of analysis based on a few large trades.

For Dec 24 will be happy with 6.8p. Again anything higher would be a personal project well ahead of schedule.

Fully disagree, I was here before the RTO, building a free position prior to it, by buying heavy prior to suspension, and then reducing through placing price hikes, but have added again since aggressively, and after two years there has been plenty of updates. It’s a business headed by a champion in cancer research with partnerships in China and the USA. We have been shafted price wise ONLY by short term holders and traders who will continue to be shafted for the rest of their lives unless they take responsibility for their own actions. Last year was meant to be the year of progression and it will continue into 2023 and beyond.

From what I see, it would have been profitable both ways. Had CIZ remained in the current agreement with SGSC and Conduit, they would have been paid royalties of 5% for their economic interest in the commercialisation of the AZD 1656.
However as far as I can gather in total CIZ has paid just over £2m in raised proceeds from shares subscribed either by Conduit or private investors.
The put option now technically puts a floor value of around £3.25m minimum, and so CIZ has the best of both worlds? They can hold on to the current deal and gain royalties or sell the put option for anything around £3.25m or north of that and take shares in Conduit when they list on the NASDAQ.
I can see why Dr Allan Syms says "I am delighted to secure this transaction with Conduit, which upon exercise of the Option, is intended to give Cizzle exposure to the entire portfolio of Conduit as a shareholder, and in due course provide listed securities which Cizzle will have flexibility to monetise. The consideration pursuant to the Option represents a significant premium to our investment in initially securing royalty rights in AZD1656."

https://www.dvmarketresearch.com/vietnam-tonic-water-market/

https://tophotel.news/country-overview-123-hotels-to-open-across-vietnam-infographic/

Top five hotel construction projects that commenced in Vietnam in Q2 2022

1. Cadia Qui Nhon Mixed-Use Development – $320m ...
2. Iron Market Commercial Complex – $242m ...
3. Crystal Holidays Harbor Van Don Tourism Resort and Entertainment Complex – $155m ...
4. Cat Linh Van Don luxury hotel and apartment complex – $150m ...
5. Courtyard by Marriott Quy Nhon Hotel – $50m

https://www.londonstockexchange.com/news-article/EISB/vietnam-distribution-agreement/15748934

Hopefully a great first day and going forward and also great help to those that need it medically.

7min 32 secs Tony Burt "Listeners have to remember that outside of the UK is only a couple of real global players in premium mixers and we are one of them, and so Asia makes up 60% of the world's population, so you know there is incredible opportunity for us in the Asia Pacific."

Really pleased with today going forward.

There are two groups looking at this. One obsessed on price and the second one looking at the actual business.
The price was pitched at 0.47p on return and what would have happened, be honest! A lot of holders would have sold for peanut profits and be happy they got their money back. The price would then have sat back at around 0.3p and then the same sellers would have then been in and out all day everyday dragging the price. We then go nowhere fast.

At 0.3p those who wanted 0.47p are now in a mire not knowing what to do. Get their money back would be my first guest. Those looking at the growth in the cannabis industry and going forward will no doubt be adding.

I could be reading it wrong but from some of the posts its blatantly clear some like showing their cards.

Widglide

Clearly the market does take the RNS as positive. Your problem is twofold. You are down heavily on this stock and you are mixing too many personal variables into the mix which then muddles up your outcome. You are now not seeing it for the business it is which then put fear into you adding more, and so you sit watching patiently at break even, pondering whether that would be possible and a good time to get out.

No one can stop the early morning buyer of 253k shares who then sells 7 minutes later for a loss or a small £10 profit. Each to their own! The fact that close to 50% is held by solid institutions give confidence that when company changing news does land, our 253k friend will have real problems filling that and making £10 profit.

Widglide, the price could and should be maybe closer to 3p, but while it is down here, some of us can throw spare money at this because the opportunity is there and we are well aware of the risks of any investment. Block out the noise if you can and makes a massive amount of difference. If you don’t then I expect more of the same from you and you will be your own enemy.

CorePath Laboratories
@CorePath
·
21s
Thank you Dr. Allan Syms Exec. Chairman of
@CizzlePlc
for visiting CorePath. Excited to continue partnership to develop & offer a proprietary #earlystage #lungcancer test throughout the USA.

On track to validating/commercializing the test in 2023.

Its only been 15 mins since my last post and it has gone from 1.5% to 18% up. Catching up started.

Agreed Aimtrader we have some catching up, but the difference is Herd V Investors. There are loads who will follow the herd and very few who have the patience to invest. That is reflected here. The buys this morning apart from a few have all in the main being those adding to the current holding, in my opinion. In Vela no idea other than the frequency and speed of trading indicates traders not investors.

CIZ will have its day, very soon. I am trying to put together AS has indicated a trip to the USA in the very week that Conduit have announced a NASDAQ listing. The partnership looks very healthy, so hopefully there will be more to this. I was very impressed by the work they do, but was left confused as to why they sold out their share in CIZ. Not sure about what they have done with the latest tranche in CIZ?

The fact that Taylor Partners Limited has sold down 12m odd shares has given others the chance to add more at these cheap levels. If they have stopped then I expect a correction back upwards

Agreed Jace
End game for me too. No reason to sell. Saving lives is the priority, and if the investment grows from it, so be it.

Good luck mate.